Islam et al., 2001 - Google Patents
Influence of vaccine deposition site on post-vaccinal viraemia and vaccine efficacy in broiler chickens following in ovo vaccination against Marek's diseaseIslam et al., 2001
View PDF- Document ID
- 8681903330219980023
- Author
- Islam A
- Walkden-Brown S
- Wong C
- Groves P
- Burgess S
- Arzey K
- Young P
- Publication year
- Publication venue
- Avian Pathology
External Links
Snippet
In ovo vaccination against Marek's disease is a widely used technology in the broiler industry. A series of experiments was carried out to determine the site of vaccine deposition in the egg during automated in ovo vaccination, and the effect of vaccine deposition site and …
- 229960005486 vaccines 0 title abstract description 131
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
- C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Witter | The changing landscape of Marek's disease | |
| Ricks et al. | In ovo vaccination technology | |
| Nair et al. | Neoplastic diseases | |
| Mayers et al. | The role of vaccination in risk mitigation and control of Newcastle disease in poultry | |
| Sultan et al. | Protective efficacy of the Newcastle disease virus genotype VII–matched vaccine in commercial layers | |
| Capua et al. | H7N1 avian influenza in Italy (1999 to 2000) in intensively reared chickens and turkeys | |
| MORIMURA et al. | Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine | |
| JPH07504320A (en) | Gene transfer to birds by introducing DNA into muscles in ovo | |
| Van der Heide et al. | Development of an attenuated apathogenic reovirus vaccine against viral arthritis/tenosynovitis | |
| Upadhayay et al. | Recent Trends in Diagnosis and Control of Marek's Disease (MD) in Poultry" Shambhu Dayal Singh," Rajamani Barathidasan," Asok Kumar,“Rajib Deb," Amit Kumar Verma and" Kuldeep Dhama" Avian Diseases Section, Division of Pathology, Indian Veterinary Research Institute | |
| Islam et al. | Influence of vaccine deposition site on post-vaccinal viraemia and vaccine efficacy in broiler chickens following in ovo vaccination against Marek's disease | |
| EP1035203A1 (en) | Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants | |
| Kurukulasuriya et al. | Modified live infectious bursal disease virus (IBDV) vaccine delays infection of neonatal broiler chickens with variant IBDV compared to turkey herpesvirus (HVT)-IBDV vectored vaccine | |
| Wagari | A review on infectious bursal disease in poultry | |
| GB2229440A (en) | Introducing an exogenous gene into birds. | |
| CN110680914B (en) | Triple inactivated vaccine and preparation method thereof | |
| CN114395536B (en) | Avian adenovirus type 4, 8 and 11 trivalent vaccine and preparation method and application thereof | |
| JPH08187076A (en) | Raw T. coli produced by enriched tissue culture prior to commercial scale harvesting. T. gondi bradyzoites, and products and methods | |
| KR102340265B1 (en) | Avian reovirus vaccines | |
| Santin et al. | Examination of the effect of a naturally occurring mutation in glycoprotein L on Marek's disease virus pathogenesis | |
| US6451321B1 (en) | IBDV strain in ovo administration | |
| KR100540856B1 (en) | Intravaginal Vaccination Against Newcastle Disease | |
| KR101511712B1 (en) | Novel infectious bursal disease virus IBD K7 and infectious bursal disease vaccine using the same | |
| KR20110045648A (en) | Novel type Avian meth pneumovirus SC1509 strains prevalent in domestically raised chickens and uses thereof | |
| CN116042537A (en) | Avian reovirus strain QYH2020-QD, virus liquid, preparation method and application |